Published on 04/10/2024
Rwanda is intensifying efforts to secure vaccines for the Marburg virus, as stated by Health Minister Dr. Sabin Nsanzimana on October 2 during an interview on Rwanda Television.
While no approved vaccines are currently available, the minister is optimistic about receiving doses soon, thanks to collaboration with the World Health Organization (WHO) to fast-track clinical trials.
Currently, Rwanda has confirmed 36 cases of Marburg virus disease, with 25 individuals in isolation and 11 deaths. While awaiting vaccines, the country is providing supportive care to manage symptoms and investigating new treatments that are still in development, as Dr. Nsanzimana emphasized. Securing vaccines and therapeutics is vital to saving lives and curbing the virus’s spread.
WHO’s Country Representative to Rwanda, Dr. Brian Chirombo, highlighted the challenges in developing a vaccine, explaining that limited cases in past outbreaks hindered extensive trials. However, Rwanda is one of 17 countries prepared to conduct trials quickly if the opportunity arises.
Efforts to contain the virus include handwashing stations at public locations, such as markets and restaurants, following new guidelines from the Ministry of Health. Hospital visits have been suspended, and strict hygiene measures are being reinforced. The Ministry also restricted funeral services for Marburg-related deaths, limiting attendance to 50 people and banning open-casket viewings.
The public is urged to remain vigilant, with anyone experiencing symptoms like high fever, severe headache, vomiting, or muscle pain encouraged to contact the Rwanda Biomedical Centre (RBC) at toll-free number 114 or visit the nearest health facility.
